These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25881630)

  • 1. Role of age and sex in the diagnosis of early-stage malignant melanoma: a cross-sectional study.
    Moreno-Ramírez D; Ojeda-Vila T; Ríos-Martín JJ; Nieto-García A; Ferrándiz L
    Acta Derm Venereol; 2015 Nov; 95(8):940-2. PubMed ID: 25881630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between tumor size and Breslow's thickness in malignant melanoma: a cross-sectional, multicenter study.
    Moreno-Ramírez D; Ojeda-Vila T; Ríos-Martín JJ; Nieto-García A; Ferrándiz L
    Melanoma Res; 2015 Oct; 25(5):450-2. PubMed ID: 26237766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: a cross-sectional study.
    Moreno-Ramírez D; Ojeda-Vila T; Ríos-Martín JJ; Ruiz-Villaverde R; de-Troya M; Sanz-Trelles A; Liébana RF; Martínez-de-Victoria JM; Aneiros-Fernández J; Naranjo-Sintes R; Amérigo J; Alcalde M; Zulueta T; Domínguez-Cruz JJ; Solís-García E; Tejera-Vaquerizo A; Martín-Castro AM; García-Mellado V; Martínez-García S; Martínez-García A; Herrera-Acosta E; Escámez PJ; Rodríguez-Fernández AM; Salvatierra-Cuenca J; Moreno-Giménez JC; Guerrero-Cauqui R; Armario-Hita JC; Nieto-Garcia A; Ferrándiz L
    J Am Acad Dermatol; 2014 Sep; 71(3):507-15. PubMed ID: 24894454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
    van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
    Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and survival of patients with invasive amelanotic melanoma in the USA.
    Moreau JF; Weissfeld JL; Ferris LK
    Melanoma Res; 2013 Oct; 23(5):408-13. PubMed ID: 23883947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma thickness: the role of patients' characteristics, risk indicators and patterns of diagnosis.
    Haenssle HA; Hoffmann S; Holzkamp R; Samhaber K; Lockmann A; Fliesser M; Emmert S; Schön MP; Rosenberger A; Buhl T
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):102-8. PubMed ID: 24646029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes in patients with multiple primary melanomas.
    Rowe CJ; Law MH; Palmer JM; MacGregor S; Hayward NK; Khosrotehrani K
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2120-7. PubMed ID: 25864459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic features of cutaneous melanoma in a dermatology referral centre in Tehran, Iran.
    Kamyab K; Kazemi S; Azimi P; Azizpour A; Ghandi N; Pirooz E; Noormohammadpour P; Mirshams-Shahshahani M; Daneshpazhooh M
    Australas J Dermatol; 2017 Nov; 58(4):e228-e231. PubMed ID: 28295169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
    Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
    Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
    Palangié A; Lassau F; Moreau T; Noury-Duperrat G; Cottenot F
    Nouv Presse Med; 1981 Jun; 10(28):2337-41. PubMed ID: 7267338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of primary cutaneous melanoma: a single centre analysis of a Swiss regional population.
    Heppt MV; Reinholz M; Tietze JK; Kerl K; French LE; Berking C; Kamarashev J
    Eur J Dermatol; 2015 Apr; 25(2):127-32. PubMed ID: 25787976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980.
    van der Spek-Keijser LM; van der Rhee HJ; Tóth G; Van Westering R; Bruijn JA; Coebergh JW
    Br J Dermatol; 1997 Apr; 136(4):565-71. PubMed ID: 9155959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the diagnosis of primary cutaneous melanoma in the public and private healthcare systems in Joinville, Santa Catarina State, Brazil.
    Steglich RB; Cardoso S; Gaertner MHDCN; Coelho KMPA; Cestari TF; Franco SC
    An Bras Dermatol; 2018; 93(4):507-512. PubMed ID: 30066755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess body weight and increased Breslow thickness in melanoma patients: a retrospective study.
    de Giorgi V; Gori A; Papi F; Grazzini M; Rossari S; Verdelli A; Crocetti E; Savarese I; Giorgi L; Massi D
    Eur J Cancer Prev; 2013 Sep; 22(5):480-5. PubMed ID: 23462459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
    Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
    JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apropos of 371 cases of malignant melanoblastomas of the skin and orifices. Factors of prognosis].
    Dargent M; Colon J; Estigarribia A
    Ann Chir; 1970 Feb; 24(3):151-78. PubMed ID: 5419383
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.